{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T12:41:27Z","timestamp":1794746487991,"version":"4.9.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Manipal University Jaipur"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-56242-w","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T08:32:30Z","timestamp":1784795550000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Quantitative correlation of spectroscopic signatures with ligand\u2013protein interactions in anti-cancer drug Afinitor: an integrated experimental\u2013computational study"],"prefix":"10.1038","volume":"16","author":[{"given":"P. Venkata","family":"Ramana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashmirekha","family":"Ram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasadarao","family":"Bobbili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y. Rama","family":"Krishna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabinarayan","family":"Panda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouri","family":"Dominic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratap Kumar","family":"Dakua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddharth","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"issue":"3","key":"56242_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/CAAC.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71(3), 209\u2013249. https:\/\/doi.org\/10.3322\/CAAC.21660 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"56242_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/PH13050095","author":"T Asatsuma-Okumura","year":"2020","unstructured":"Asatsuma-Okumura, T., Ito, T. & Handa, H. Molecular mechanisms of the teratogenic effects of thalidomide. Pharmaceuticals https:\/\/doi.org\/10.3390\/PH13050095 (2020).","journal-title":"Pharmaceuticals"},{"key":"56242_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/B978-008055232-3.64074-7","author":"V Beljanski","year":"2008","unstructured":"Beljanski, V. Everolimus. xPharm Compr. Pharmacol. https:\/\/doi.org\/10.1016\/B978-008055232-3.64074-7 (2008).","journal-title":"xPharm Compr. Pharmacol."},{"key":"56242_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-323-35762-3.00057-3","author":"SL Gerson","year":"2018","unstructured":"Gerson, S. L., Caimi, P. F., William, B. M. & Creger, R. J. Pharmacology and Molecular Mechanisms of Antineoplastic Agents for Hematologic Malignancies. Hematol. Basic Princ. Pract. https:\/\/doi.org\/10.1016\/B978-0-323-35762-3.00057-3 (2018).","journal-title":"Hematol. Basic Princ. Pract."},{"key":"56242_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/J.EJMECH.2020.112820","author":"Y Chen","year":"2020","unstructured":"Chen, Y. & Zhou, X. Research progress of mTOR inhibitors. Eur. J. Med. Chem. https:\/\/doi.org\/10.1016\/J.EJMECH.2020.112820 (2020).","journal-title":"Eur. J. Med. Chem."},{"key":"56242_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-323-47674-4.00079-7","author":"MA McNamara","year":"2020","unstructured":"McNamara, M. A., Zhang, T., Harrison, M. R. & George, D. J. Cancer of the Kidney. Abeloff\u2019s Clin. Oncol. https:\/\/doi.org\/10.1016\/B978-0-323-47674-4.00079-7 (2020).","journal-title":"Abeloff\u2019s Clin. Oncol."},{"issue":"9","key":"56242_CR7","doi-asserted-by":"publisher","first-page":"752","DOI":"10.3109\/00498254.2011.573882","volume":"41","author":"N Picard","year":"2011","unstructured":"Picard, N. et al. Interaction of sirolimus and everolimus with hepatic and intestinal organic anion-transporting polypeptide transporters. Xenobiotica 41(9), 752\u2013757. https:\/\/doi.org\/10.3109\/00498254.2011.573882 (2011).","journal-title":"Xenobiotica"},{"issue":"19","key":"56242_CR8","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1056\/NEJMOA1001671","volume":"363","author":"DA Krueger","year":"2010","unstructured":"Krueger, D. A. et al. Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis. N. Engl. J. Med. 363(19), 1801\u20131811. https:\/\/doi.org\/10.1056\/NEJMOA1001671 (2010).","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"56242_CR9","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1517\/13543784.2010.499121","volume":"19","author":"S Albert","year":"2010","unstructured":"Albert, S. et al. New inhibitors of the mammalian target of rapamycin signaling pathway for cancer. Expert Opin. Investig. Drugs 19(8), 919\u2013930. https:\/\/doi.org\/10.1517\/13543784.2010.499121 (2010).","journal-title":"Expert Opin. Investig. Drugs"},{"key":"56242_CR10","unstructured":"AFINITOR & AFINITOR DISPERZ | HCP Website. Accessed: Oct. 25, 2021. [Online]. Available: https:\/\/www.hcp.novartis.com\/products\/afinitor\/"},{"key":"56242_CR11","doi-asserted-by":"publisher","DOI":"10.1533\/9781845697488.2.118","author":"K Vedantham","year":"2010","unstructured":"Vedantham, K., Chaterji, S., Kitsongsermthon, J., Park, K. & Garner, J. Future outlook for drug eluting stents. Drug-Device Comb. Prod. Deliv. Technol. Appl. https:\/\/doi.org\/10.1533\/9781845697488.2.118 (2010).","journal-title":"Drug-Device Comb. Prod. Deliv. Technol. Appl."},{"key":"56242_CR12","unstructured":"Spectrum Two FT-IR Spectrometer with LiTaO3 Detector | PerkinElmer. Accessed: Oct. 25, 2021. [Online]. Available: https:\/\/www.perkinelmer.com\/uk\/product\/spectrum-two-ft-ir-sp10-software-l160000a"},{"key":"56242_CR13","unstructured":"UV\/Vis\/NIR Spectrophotometers and Accessories | PerkinElmer. Accessed: Oct. 25, 2021. [Online]. Available: https:\/\/www.perkinelmer.com\/uk\/category\/uv-vis-spectroscopy-uv"},{"key":"56242_CR14","unstructured":"IR Spectrum Table. Accessed: Oct. 25, 2021. [Online]. Available: https:\/\/www.sigmaaldrich.com\/IN\/en\/technical-documents\/technical-article\/analytical-chemistry\/photometry-and-reflectometry\/ir-spectrum-table"},{"key":"56242_CR15","unstructured":"IR table. Accessed: Oct. 25, 2021. [Online]. Available: https:\/\/www.chem.ucla.edu\/~bacher\/General\/30BL\/IR\/ir.html"},{"key":"56242_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2022.133051","volume":"1263","author":"PV Ramana","year":"2022","unstructured":"Ramana, P. V., Krishna, Y. R. & Mouli, K. C. Experimental FT-IR and UV-Vis spectroscopic studies and molecular docking analysis of anti-cancer drugs Exemestane and Pazopanib. J. Mol. Struct. 1263, 133051. https:\/\/doi.org\/10.1016\/j.molstruc.2022.133051 (2022).","journal-title":"J. Mol. Struct."},{"key":"56242_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2021.132211","volume":"1253","author":"PV Ramana","year":"2022","unstructured":"Ramana, P. V. et al. Spectroscopic, quantum mechanical, electronic excitation properties (ethanol solvent), DFT investigations and molecular docking analysis of an anti-cancer drug Bendamustine. J. Mol. Struct. 1253, 132211. https:\/\/doi.org\/10.1016\/j.molstruc.2021.132211 (2022).","journal-title":"J. Mol. Struct."},{"key":"56242_CR18","unstructured":"Beauchamp Spectroscopy Tables 1."},{"issue":"no. March","key":"56242_CR19","doi-asserted-by":"publisher","first-page":"103532","DOI":"10.1016\/j.vibspec.2023.103532","volume":"126","author":"KV Prasad","year":"2023","unstructured":"Prasad, K. V. & Ramana, P. V. Vibrational spectroscopic studies, DFT, and molecular docking investigations of 4-fluoro- 3-methyl benzophenone. Vib. Spectrosc. 126(March), 103532. https:\/\/doi.org\/10.1016\/j.vibspec.2023.103532 (2023).","journal-title":"Vib. Spectrosc."},{"key":"56242_CR20","unstructured":"Infrared Spectra: Identifying Functional Groups. Accessed: Oct. 25, 2021. [Online]. Available: https:\/\/sites.science.oregonstate.edu\/~gablek\/CH335\/Chapter10\/IR.htm"},{"key":"56242_CR21","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/J.SAA.2014.06.140","volume":"135","author":"YS Mary","year":"2015","unstructured":"Mary, Y. S. et al. Molecular structure, FT-IR, NBO, HOMO and LUMO, MEP and first order hyperpolarizability of (2E)-1-(2,4-Dichlorophenyl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one by HF and density functional methods. Spectrochim. Acta A Mol. Biomol. Spectrosc. 135, 81\u201392. https:\/\/doi.org\/10.1016\/J.SAA.2014.06.140 (2015).","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"56242_CR22","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/J.SAA.2014.06.029","volume":"134","author":"S Muthunatesan","year":"2015","unstructured":"Muthunatesan, S. & Ragavendran, V. A study of vibrational spectra and investigations of charge transfer and chemical bonding features of 2-chloro benzimidazole based on DFT computations. Spectrochim. Acta A Mol. Biomol. Spectrosc. 134, 148\u2013154. https:\/\/doi.org\/10.1016\/J.SAA.2014.06.029 (2015).","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"56242_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2022.133984","volume":"1270","author":"PV Ramana","year":"2022","unstructured":"Ramana, P. V., Krishna, Y. R. & Mouli, K. C. Experimental ( FT-IR, UV-Vis ) spectroscopic analysis and molecular docking investigations of anti-cancer drugs Alkeran and Bicalutamide. J. Mol. Struct. 1270, 133984 (2022).","journal-title":"J. Mol. Struct."},{"key":"56242_CR24","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/J.MOLSTRUC.2016.09.037","volume":"1128","author":"KV Prasad","year":"2017","unstructured":"Prasad, K. V., Muthu, S. & Santhamma, C. Spectroscopic (FT-IR, FT-Raman, UV\u2013Visible) and quantum chemical studies of 4-Chloro-3-iodobenzophenone. J. Mol. Struct. 1128, 685\u2013693. https:\/\/doi.org\/10.1016\/J.MOLSTRUC.2016.09.037 (2017).","journal-title":"J. Mol. Struct."},{"key":"56242_CR25","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.saa.2015.07.001","volume":"151","author":"KV Prasad","year":"2015","unstructured":"Prasad, K. V. et al. Spectroscopic studies (FT-IR, FT-Raman, UV-Visible), normal co-ordinate analysis, first-order hyperpolarizability and HOMO, LUMO studies of 3,4-dichlorobenzophenone by using density functional methods. Spectrochim. Acta A Mol. Biomol. Spectrosc. 151, 644\u2013654. https:\/\/doi.org\/10.1016\/j.saa.2015.07.001 (2015).","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"issue":"no. 11","key":"56242_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S00214-023-03055-Z","volume":"142","author":"PV Ramana","year":"2023","unstructured":"Ramana, P. V. Experimental spectroscopic and molecular docking investigations of the anticancer drugs Aprepitant and Capecitabine. Theor. Chem. Acc. 142(11), 1\u201320. https:\/\/doi.org\/10.1007\/S00214-023-03055-Z (2023).","journal-title":"Theor. Chem. Acc."},{"issue":"no. 29","key":"56242_CR27","doi-asserted-by":"publisher","first-page":"9301","DOI":"10.1021\/JP062438C","volume":"110","author":"MAV Ribeiro da Silva","year":"2006","unstructured":"Ribeiro da Silva, M. A. V., Amaral, L. M. P. F. & Gomes, J. R. B. Experimental and computational investigation of the thermochemistry of the six isomers of dichloroaniline. J. Phys. Chem. A 110(29), 9301\u20139306. https:\/\/doi.org\/10.1021\/JP062438C (2006).","journal-title":"J. Phys. Chem. A"},{"key":"56242_CR28","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/J.MOLSTRUC.2016.09.059","volume":"1129","author":"VV Menon","year":"2017","unstructured":"Menon, V. V. et al. Vibrational spectroscopic analysis, molecular dynamics simulations and molecular docking study of 5-nitro-2-phenoxymethyl benzimidazole. J. Mol. Struct. 1129, 86\u201397. https:\/\/doi.org\/10.1016\/J.MOLSTRUC.2016.09.059 (2017).","journal-title":"J. Mol. Struct."},{"key":"56242_CR29","unstructured":"RCSB PDB - 1FKL: ATOMIC STRUCTURE OF FKBP12-RAPAYMYCIN, AN IMMUNOPHILIN-IMMUNOSUPPRESSANT COMPLEX. Accessed: Oct. 25, 2021. [Online]. Available: https:\/\/www.rcsb.org\/structure\/1FKL"},{"issue":"4","key":"56242_CR30","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1107\/S0907444994014514","volume":"51","author":"KP Wilson","year":"1995","unstructured":"Wilson, K. P. et al. Comparative X-ray structures of the major binding protein for the immunosuppressant FK506 (tacrolimus) in unliganded form and in complex with FK506 and rapamycin. Acta Crystallogr. Sect. D Biol. Crystallogr. 51(4), 511\u2013521. https:\/\/doi.org\/10.1107\/S0907444994014514 (1995).","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"56242_CR31","unstructured":"Everolimus: Uses, Interactions, Mechanism of Action | DrugBank Online. Accessed: Oct. 25, 2021. [Online]. Available: https:\/\/go.drugbank.com\/drugs\/DB01590"},{"key":"56242_CR32","unstructured":"AutoDock Vina. Accessed: Oct. 25, 2021. [Online]. Available: https:\/\/vina.scripps.edu\/"},{"key":"56242_CR33","unstructured":"Free Download: BIOVIA Discovery Studio Visualizer - Dassault Syst\u00e8mes. Accessed: Sep. 06, 2021. [Online]. Available: https:\/\/discover.3ds.com\/discovery-studio-visualizer-download"},{"issue":"1","key":"56242_CR34","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s11696-021-01843-0","volume":"76","author":"M Arooj","year":"2022","unstructured":"Arooj, M., Shehadi, I., Nassab, C. N. & Mohamed, A. A. Computational insights into binding mechanism of drugs as potential inhibitors against SARS-CoV-2 targets. Chem. Pap. 76(1), 111\u2013121. https:\/\/doi.org\/10.1007\/s11696-021-01843-0 (2022).","journal-title":"Chem. Pap."},{"issue":"February","key":"56242_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.rechem.2025.102369","volume":"16","author":"PV Ramana","year":"2025","unstructured":"Ramana, P. V., Krishna, Y. R., Bobbili, P., Prasad, K. V. & Mouli, K. C. Investigation of the anti-cancer drugs imatinib and thalidomide using analytical spectroscopy (FT-IR, UV-Vis) and molecular docking simulations. Results Chem. 16(February), 102369. https:\/\/doi.org\/10.1016\/j.rechem.2025.102369 (2025).","journal-title":"Results Chem."},{"issue":"7","key":"56242_CR36","doi-asserted-by":"publisher","first-page":"13384","DOI":"10.3390\/molecules200713384","volume":"20","author":"LG Ferreira","year":"2015","unstructured":"Ferreira, L. G., Dos Santos, R. N., Oliva, G. & Andricopulo, A. D. Molecular docking and structure-based drug design strategies. Molecules 20(7), 13384\u201313421. https:\/\/doi.org\/10.3390\/molecules200713384 (2015).","journal-title":"Molecules"},{"key":"56242_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/J.MOLSTRUC.2024.141107","volume":"1326","author":"PP Patel","year":"2025","unstructured":"Patel, P. P. et al. Exploring the antimicrobial and antitubercular potential of 1-Thia-4-azaspiro[4.5]decan-3-one derivatives: Synthesis, molecular docking, and MD simulations. J. Mol. Struct. 1326, 141107. https:\/\/doi.org\/10.1016\/J.MOLSTRUC.2024.141107 (2025).","journal-title":"J. Mol. Struct."},{"key":"56242_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/J.LWT.2024.117135","volume":"214","author":"Z Pan","year":"2024","unstructured":"Pan, Z. et al. Integrating convolutional neural networks with UV\u2013Vis spectroscopy for monitoring the extraction procedure of Ganoderma lucidum spore powder. LWT 214, 117135. https:\/\/doi.org\/10.1016\/J.LWT.2024.117135 (2024).","journal-title":"LWT"},{"key":"56242_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/J.VIBSPEC.2024.103733","volume":"135","author":"P Thongnopkun","year":"2024","unstructured":"Thongnopkun, P. Efficient identification and distinction of musgravite and taaffeite with the utilization of ATR-FTIR spectroscopy and Raman spectroscopy. Vib. Spectrosc. 135, 103733. https:\/\/doi.org\/10.1016\/J.VIBSPEC.2024.103733 (2024).","journal-title":"Vib. Spectrosc."},{"key":"56242_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/J.MICPATH.2024.107209","author":"DD Babu","year":"2024","unstructured":"Babu, D. D. et al. Computational and Experimental Insights into Pharmacological Potential: Synthesis, In Vitro Evaluation, and Molecular Docking Analysis of Bioactive Urea and Thiourea Derivatives. Microb. Pathog. https:\/\/doi.org\/10.1016\/J.MICPATH.2024.107209 (2024).","journal-title":"Microb. Pathog."},{"issue":"5","key":"56242_CR41","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1080\/05704928.2021.1958337","volume":"57","author":"EL Callery","year":"2022","unstructured":"Callery, E. L. & Rowbottom, A. W. Vibrational spectroscopy and multivariate analysis techniques in the clinical immunology laboratory: A review of current applications and requirements for diagnostic use. Appl. Spectrosc. Rev. 57(5), 411\u2013440. https:\/\/doi.org\/10.1080\/05704928.2021.1958337 (2022).","journal-title":"Appl. Spectrosc. Rev."},{"issue":"7","key":"56242_CR42","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1080\/08927022.2011.640936","volume":"38","author":"E Romano","year":"2012","unstructured":"Romano, E., Soria, N. A. J., Rudyk, R. & Brand\u00e1n, S. A. Theoretical study of the infrared spectrum of 5-phenyl-1,3,4-oxadiazole-2-thiol by using DFT calculations. Mol. Simul. 38(7), 561\u2013566. https:\/\/doi.org\/10.1080\/08927022.2011.640936 (2012).","journal-title":"Mol. Simul."},{"key":"56242_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/J.CPT.2024.11.002","author":"VC Deivayanai","year":"2024","unstructured":"Deivayanai, V. C. et al. A comprehensive review on advances in nanoparticle-mediated cancer therapeutics: Current research and future perspectives. Cancer Pathog. Ther. https:\/\/doi.org\/10.1016\/J.CPT.2024.11.002 (2024).","journal-title":"Cancer Pathog. Ther."},{"issue":"6","key":"56242_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/J.DRUDIS.2024.104010","volume":"29","author":"MJ Nutt","year":"2024","unstructured":"Nutt, M. J. & Stewart, S. G. Strengthening molecular glues: Design strategies for improving Thalidomide analogs as Cereblon effectors and anticancer agents. Drug Discov. Today 29(6), 104010. https:\/\/doi.org\/10.1016\/J.DRUDIS.2024.104010 (2024).","journal-title":"Drug Discov. Today"},{"key":"56242_CR45","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.csbj.2020.12.042","volume":"19","author":"LP Tangella","year":"2021","unstructured":"Tangella, L. P., Arooj, M., Deplazes, E., Gray, E. S. & Mancera, R. L. Identification and characterisation of putative drug binding sites in human ATP-binding cassette B5 (ABCB5) transporter. Comput. Struct. Biotechnol. J. 19, 691\u2013704. https:\/\/doi.org\/10.1016\/j.csbj.2020.12.042 (2021).","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"7","key":"56242_CR46","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1002\/prot.24677","volume":"83","author":"M Arooj","year":"2015","unstructured":"Arooj, M. et al. Finding off-targets, biological pathways, and target diseases for chymase inhibitors via structure-based systems biology approach. Proteins 83(7), 1209\u20131224. https:\/\/doi.org\/10.1002\/prot.24677 (2015).","journal-title":"Proteins"},{"key":"56242_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2023.137473","author":"FA Ugbe","year":"2024","unstructured":"Ugbe, F. A. et al. Computational evaluation of the inhibitory potential of some urea, thiourea, and selenourea derivatives of diselenides against leishmaniasis: 2D-QSAR, pharmacokinetics, molecular docking, and molecular dynamics simulation. J. Mol. Struct. https:\/\/doi.org\/10.1016\/j.molstruc.2023.137473 (2024).","journal-title":"J. Mol. Struct."},{"issue":"11","key":"56242_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjac.2023.100330","volume":"51","author":"K Mkhayar","year":"2023","unstructured":"Mkhayar, K. et al. Evaluation of dimedone-derived compounds as inhibitors against human colon cancer: Insights from 2D-QSAR, ADMET prediction, Osiris, Molinspiration, and molecular modeling. Chin. J. Anal. Chem. 51(11), 100330. https:\/\/doi.org\/10.1016\/j.cjac.2023.100330 (2023).","journal-title":"Chin. J. Anal. Chem."},{"issue":"1","key":"56242_CR49","doi-asserted-by":"publisher","DOI":"10.1007\/s44371-024-00026-6","volume":"1","author":"FA Ugbe","year":"2024","unstructured":"Ugbe, F. A. et al. Cheminformatic evaluation of the multi-protein binding potential of some diselenide derivatives: A plausible drug discovery approach for leishmaniasis. Discov. Chem. 1(1), 25. https:\/\/doi.org\/10.1007\/s44371-024-00026-6 (2024) (Oct. 2024).","journal-title":"Discov. Chem."},{"key":"56242_CR50","doi-asserted-by":"publisher","first-page":"100162","DOI":"10.1016\/j.insi.2025.100162","volume":"2","author":"EI Edache","year":"2026","unstructured":"Edache, E. I., Albutti, A. & Ugbe, F. A. Unveiling the structural and retrosynthetic mechanism of some 2-aziridinyl- and 2,3-bis(aziridinyl)-1,4-naphthoquinonyl sulfonate and acylate compounds as treatment of malaria parasite, Plasmodium falciparum: Binding free energy calculatio\u2026. Silico Res. Biomed. 2, 100162. https:\/\/doi.org\/10.1016\/j.insi.2025.100162 (2026).","journal-title":"Silico Res. Biomed."},{"issue":"3","key":"56242_CR51","doi-asserted-by":"publisher","first-page":"229","DOI":"10.33084\/bjop.v6i3.4915","volume":"6","author":"A Uzairu","year":"2023","unstructured":"Uzairu, A., Mamza, P. A., Shallangwa, G. A. & Edache, E. I. 2D-QSAR, docking, molecular dynamics simulations with the MM\/GBSA approaches against Graves\u2019 disease and PTPN22. Borneo J. Pharm. 6(3), 229\u2013248. https:\/\/doi.org\/10.33084\/bjop.v6i3.4915 (2023).","journal-title":"Borneo J. Pharm."},{"issue":"9","key":"56242_CR52","first-page":"e12831","volume":"6","author":"VO Apeh","year":"2024","unstructured":"Apeh, V. O. et al. Exploring the potential of aqueous extracts of Artemisia annua ANAMED (A3) for developing new anti-malarial agents: In vivo and silico computational approach. Eng. Rep. 6(9), e12831 (2024).","journal-title":"Eng. Rep."},{"key":"56242_CR53","volume-title":"Infrared and Raman Characteristic Group Frequencies: Tables and Charts","author":"G Socrates","year":"2001","unstructured":"Socrates, G. Infrared and Raman Characteristic Group Frequencies: Tables and Charts 3rd ed. (Wiley, 2001).","edition":"3rd ed"},{"issue":"2","key":"56242_CR54","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1088\/0034-4885\/51\/2\/001","volume":"51","author":"JP Connerade","year":"1988","unstructured":"Connerade, J. P. & Lane, A. M. The role of electron density in molecular interactions. Rep. Prog. Phys. 51(2), 143\u2013198 (1988).","journal-title":"Rep. Prog. Phys."},{"key":"56242_CR55","volume-title":"The Weak Hydrogen Bond in Structural Chemistry and Biology","author":"GR Desiraju","year":"1999","unstructured":"Desiraju, G. R. & Steiner, T. The Weak Hydrogen Bond in Structural Chemistry and Biology (Oxford University Press, 1999)."},{"issue":"2","key":"56242_CR56","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1039\/a827163z","volume":"27","author":"I Alkorta","year":"1998","unstructured":"Alkorta, I., Rozas, I. & Elguero, J. Non-conventional hydrogen bonds. Chem. Soc. Rev. 27(2), 163\u2013170 (1998).","journal-title":"Chem. Soc. Rev."},{"key":"56242_CR57","first-page":"365","volume-title":"Methods Mol. Biol.","author":"GM Morris","year":"2008","unstructured":"Morris, G. M. & Lim-Wilby, M. Molecular docking. In Methods Mol. Biol. Vol. 443 365\u2013382 (2008)."},{"issue":"8","key":"56242_CR58","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1517\/17460441.3.8.841","volume":"3","author":"DE Clark","year":"2008","unstructured":"Clark, D. E. What has virtual screening ever done for drug discovery?. Expert Opin. Drug Discov. 3(8), 841\u2013851 (2008).","journal-title":"Expert Opin. Drug Discov."},{"key":"56242_CR59","volume-title":"Frontier Orbitals and Organic Chemical Reactions","author":"I Fleming","year":"1976","unstructured":"Fleming, I. Frontier Orbitals and Organic Chemical Reactions (Wiley, 1976)."},{"key":"56242_CR60","volume-title":"Introduction to Computational Chemistry","author":"F Jensen","year":"2007","unstructured":"Jensen, F. Introduction to Computational Chemistry 2nd edn. (Wiley, 2007).","edition":"2"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56242-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56242-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56242-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T13:01:41Z","timestamp":1785070901000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56242-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["56242"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-56242-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"assertion":[{"value":"10 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"23078"}}